Zacks Company Profile for Accelerate Diagnostics, Inc. (AXDX : NSDQ) |
|
|
|
Company Description |
Accelerate Diagnostics, Inc. is focused on developing and commercializing instrumentation for the rapid identification and antibiotic susceptibility testing of infectious pathogens. The company is developing BACcel(TM) system, a rapid diagnostic platform for diagnosis in life-threatening bacterial infections and OptiChem(R) surface coatings for use in micro arraying components. Accelerate Diagnostics Inc., formerly known as Accelr8 Technology Corp., is based in Denver, Colorado.
Number of Employees: 220 |
|
|
|
Price / Volume Information |
Yesterday's Closing Price: $0.54 |
Daily Weekly Monthly
 |
20 Day Moving Average: 672,366 shares |
Shares Outstanding: 69.66 (millions) |
Market Capitalization: $37.87 (millions) |
Beta: 1.90 |
52 Week High: $9.36 |
52 Week Low: $0.50 |
Short Interest Ratio: |
|
% Price Change |
% Price Change Relative to S&P 500 |
4 Week |
-46.70% |
-39.97% |
12 Week |
-78.16% |
-76.00% |
Year To Date |
-89.58% |
-86.87% |
|
|
|
|
|
|
|
General Corporate Information |
Officers
Jack Phillips - President; Chief Executive Officer
John Patience - Chairman
Steve Reichling - Chief Financial Officer
Tom Brown - Director
Louise Francesconi - Director
|
|
Peer Information
Accelerate Diagnostics, Inc. (ABMD)
Accelerate Diagnostics, Inc. (DMDS)
Accelerate Diagnostics, Inc. (CPWY.)
Accelerate Diagnostics, Inc. (EQUR)
Accelerate Diagnostics, Inc. (ECIA)
Accelerate Diagnostics, Inc. (FMS)
|
|
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 00430H102
SIC: 3826
|
|
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/04/22
|
|
Share - Related Items
Shares Outstanding: 69.66
Most Recent Split Date: (:1)
Beta: 1.90
Market Capitalization: $37.87 (millions)
|
|
|
|
|
|
EPS Information |
Dividend Information |
Analyst Coverage: No |
Dividend Yield: 0.00% |
Current Fiscal Quarter EPS Consensus Estimate: $-0.33 |
Indicated Annual Dividend: $0.00 |
Current Fiscal Year EPS Consensus Estimate: $-1.33 |
Payout Ratio: |
Number of Estimates in the Fiscal Year Consensus: 1.00 |
Change In Payout Ratio: |
Estmated Long-Term EPS Growth Rate: % |
Last Dividend Paid: NA - $0.00 |
Next EPS Report Date: 08/04/22 |
|
|
|
|